SJS Investment Consulting’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.29K	Sell	19 -16	-46%	-$5.45K	﹤0.01%	983
2025 Q4	$13.9K	Buy	35 +33	+1,650%	+$14.6K	﹤0.01%	708
2025 Q3	$912	Sell	2 -2	-50%	-$814	﹤0.01%	1045
2025 Q2	$1.3K	Sell	4 -3	-43%	-$830	﹤0.01%	725
2025 Q1	$1.89K	Buy	7 +3	+75%	+$771	﹤0.01%	750
2024 Q4	$942	Sell	4 -1	-20%	-$263	﹤0.01%	1017
2024 Q3	$1.38K	Buy	5 +1	+25%	+$260	﹤0.01%	953
2024 Q2	$972	Sell	4 -1	-20%	-$158	﹤0.01%	1036
2024 Q1	$748	Buy	5 +2	+67%	+$334	﹤0.01%	1146
2023 Q4	$575	Sell	3 -4	-57%	-$681	﹤0.01%	1200
2023 Q3	$1.24K	Buy	7 +2	+40%	+$382	﹤0.01%	844
2023 Q2	$950	Buy	5 +2	+67%	+$397	﹤0.01%	919
2023 Q1	$601	Hold	3	–	–	﹤0.01%	1089
2022 Q4	$713	Buy	3 +2	+200%	+$427	﹤0.01%	1092
2022 Q3	$0	Buy	+1	New	+$191	﹤0.01%	1014